People_

Dr Raymond Li

B.Pharm M.ClinPharm PhD FACP

Honorary Senior Lecturer
Sydney Pharmacy School

Email

raymond.li@sydney.edu.au

Raymond is an Honorary Senior Lecturer at the Faculty of Medicine and Health, School of Pharmacy. He is a registered pharmacist currently practising as a senior medical advisor in the pharmaceutical industry. He completed his Bachelor of Pharmacy in 2009, and subsequently completed his PhD from the University of Sydney in 2023. He was awarded fellow of the Australasian College of Pharmacy in 2022.

Research interests

Utilizing automation and digital technologies to improve medication safety and the quality use of medicines.

Associations

Fellow of the Australasian College of Pharmacy

Themes

Health Services and Patient Safety

Keywords

Health programs, Pharmacy, Pharmacy practice, Quality Use of Medicines

Publications

By Type

Expand all

Journals

Li, R., Curtis, K., Zaidi, S., Van, C., Castelino, R. (2022). A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting. Expert Opinion on Drug Safety, 21(9), 1193-1204. [More Information]
Li, R., Curtis, K., Van, C., Tabish Razi Zaidi, S., Yeo, C., Arun Kali, C., Zaheen, M., Therese Moujalli, G., Castelino, R. (2022). Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework. European Journal of Clinical Pharmacology, 78(7), 1165-1175. [More Information]
Li, R., Curtis, K., Zaidi, S., Van, C., Thomson, A., Castelino, R. (2021). Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions. Expert Opinion on Drug Safety, 20(10), 1267-1274. [More Information]
Li, R., Curtis, K., Zaidi, S., Van, C., Castelino, R. (2020). Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis. Expert Opinion on Drug Safety, 19(6), 747-753. [More Information]
Li, R., Zaidi, S., Chen, T., Castelino, R. (2020). Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review. Pharmacoepidemiology and Drug Safety, 29(1), 1-8. [More Information]

show 2 more

By Year

Expand all

2022

Li, R., Curtis, K., Zaidi, S., Van, C., Castelino, R. (2022). A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting. Expert Opinion on Drug Safety, 21(9), 1193-1204. [More Information]
Li, R., Curtis, K., Van, C., Tabish Razi Zaidi, S., Yeo, C., Arun Kali, C., Zaheen, M., Therese Moujalli, G., Castelino, R. (2022). Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework. European Journal of Clinical Pharmacology, 78(7), 1165-1175. [More Information]

2021

Li, R., Curtis, K., Zaidi, S., Van, C., Thomson, A., Castelino, R. (2021). Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions. Expert Opinion on Drug Safety, 20(10), 1267-1274. [More Information]

2020

Li, R., Curtis, K., Zaidi, S., Van, C., Castelino, R. (2020). Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis. Expert Opinion on Drug Safety, 19(6), 747-753. [More Information]
Li, R., Zaidi, S., Chen, T., Castelino, R. (2020). Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review. Pharmacoepidemiology and Drug Safety, 29(1), 1-8. [More Information]

Grants

2020